1. We studied the effect of oral prazosin on blood pressure, plasma active renin and angiotensin I1 in 16 recumbent hypertensive patients between 09.00 and 12.00 hours.
Introduction
A drug which could control blood pressure without altering plasma renin would be of considerable use in facilitating the evaluation of hypertensive patients. Prazosin is a postsynaptic Correspondence: Dr D. McAreavey, MRC Blood Pressure Unit, Western Infirmary, Glasgow G11 6NT, Scotland, U.K.
aadrenoceptor blocker which has been reported variously not to influence plasma renin [I, 21 or to cause a decrease [3-61. However, a recent study showed that oral prazosin increased plasma renin activity in upright but not in recumbent normal volunteers [7] . No definite conclusions can be drawn from these latter results because upright posture itself stimulates renin release [8, 91. The present study was undertaken to investigate whether prazosin affects plasma renin in recumbency.
Methods

Patients
Sixteen untreated hypertensive patients aged 29-58 years (mean 43.2 years) were studied. All had normal serum sodium and potassium, and normal plasma active renin, angiotensin I1 and aldosterone concentrations. Renal function and excretion urography were normal in 15; the remaining patient had renal impairment (serum urea 13.5 mmol/l, creatinine 266 ,mnol/l) and his renal arteriogram showed unilateral branch renal artery stenosis.
Protocol
During each part of the experiment patients took a diet with a fixed known and normal content of sodium and potassium, the same on each occasion for each patient. Patients were weighed on the day before each study. All studies began at 08.45 hours after overnight recumbency and fasting, both of which were maintained until the experiment ended at 12.00 hours.
At 08. The procedure was carried out on three separate occasions:
Part Z. Untreated patients. Part ZZ. Two days after part I, patients were given prazosin (2 mg orally) immediately after the blood sample taken at 09.00 hours.
Part ZZZ. Patients were re-admitted to hospital after 3-7 (mean 4.3) weeks' treatment with prazosin alone in doses from 2 to 10 mg twice daily (mean daily dose 9.6 mg). Immediately after the blood sample at 09.00 hours and 15 h after the previous dose, the normal morning dose of prazosin was given.
Statistical methods
Data were analysed by repeated measures analysis of variance and by paired t-tests (with log transformation where appropriate).
Results
Four patients were withdrawn from the study after completing part I only because blood pressure had settled in the ward to normal levels.
A further three patients were withdrawn after part 11, two because unsatisfactory blood pressure control required the addition of other drugs and one because of the development of angina.
Part Z: untreatedpatients
There were no significant changes in blood pressure (mean systolic 162.4 f SEM 9.5 mmHg at 09.00 hours, 159.8 f 7.5 mmHg at 12.00 hours; mean diastolic 102.8 f 4.2 mmHg at 09.00 hours, 101.0 f 4.6 mmHg at 12.00 hours) or in plasma concentrations of active renin (mean 26.1 & SEM 6.2 punits at 09.00 hours, 33-1 f 8-3 p-units/ml at 12.00 hours) and angiotensin I1 (mean 17.2 f 5.0 pmol/l at 09.00 hours, 17.0 f 4.5 pmol/l at 12.00 hours) (Fig la) .
Part IZ: initial effects ofprazosin
After the initial oral dose of prazosin (2 mg) there was a significant fall in mean blood pressure (systolic 158.2 f 6.2 mmHg at 09.00 hours to 141.7 f 6-3 mmHg at 12.00 hours, P < 0.001; diastolic 105.0 f 2.4 mmHg at 09.00 hours to 85.2 f 5.0 mmHg at 12.00 hours, P < 0.001) Prazosin: blood pressure, plasma renin and angiotensin 11 459s renin and angiotensin I1 were seen in every individual and were significant and progressive from 10.00 hours onwards.
Part 111: long-term effects ofprazosin
During long-term prazosin treatment blood pressure at 09.00 hours was significantly lower than when untreated (mean systolic 145.5 f 6.1 mmHg, P < 0.05; mean diastolic 93.2 f 3 -3 mmHg, P < 0.01); plasma concentrations of active renin and angiotensin I1 were not significantly different from pretreatment measurements (27.6 ? 7.1 p-unitslml and 15.8 i-2.6 pmol/l respectively) and prazosin was detectable in serum (9 -9 f 2.8 ng/ml).
After the morning dose of prazosin, blood pressure did not change significantly (mean systolic 143-0 f 4.9 mmHg, mean diastolic 89.2 f 3.6 mmHg at 12.00 hours). However, there were again consistent progressive increases in both plasma active renin (39.1 f 7 . 8 p-units/l) and angiotensin I1 (21.7 f 3.5 pmol/l, P < 0.001) concentrations by 12.00 hours, although these changes were less marked than after the initial dose of prazosin. There were no significant changes in serum electrolytes and packed cell volume or in weight or in heart rate in any part of the study.
Discussion
In untreated recumbent hypertensive patients the absence of change in blood pressure, active renin and angiotensin I1 concentrations between 09.00 and 12.00 hours is in agreement with several previous reports [12-141. Gordon et al. [151 found a slight fall in plasma renin activity during the late morning in normal subjects on a low sodium diet.
After an initial dose of 2 mg of prazosin, active renin rose progressively by 97% and angiotensin I1 by 77% within 3 h. These results are therefore at variance with several previous reports [2,4,71. The rises in renin and angiotensin I1 after an initial dose of prazosin probably result from several stimuli. Systolic and diastolic blood pressure fell by some 20 mmHg and such changes could directly cause release of renin from the juxtaglomerular cells [91. Plasma noradrenaline We found no change in blood pressure in the 3 h after the morning dose of prazosin, although there were again consistent, albeit less-marked increases in both plasma active renin and angiotensin I1 concentrations respectively of 42% and 37% within 3 h. Stimulation of renal arterial baroreceptors cannot be invoked as contributory at this stage. However, an increase in catecholamines, either within the circulation or at the juxtaglomerular presynaptic nerve endings [ 221, could be partly responsible. Elimination by prazosin of the inhibitory effect of a-adrenoceptors could also again contribute.
We conclude therefore that oral prazosin stimulates the renin-angiotensin system in recumbent subjects. This effect was seen consistently with independent assays of two different components, active renin and angiotensin 11. Stimulation was more marked after the initial dose of prazosin, when recumbent blood pressure fell, but was also seen during long-term treatment with prazosin alone. Nevertheless, as the stimulant effect was not apparent 15 h after the last dose of prazosin, the drug may be useful in the assessment of hypertensive patients in permitting an evaluation of the renin-angiotensin system. This aspect is being examined further.
